Leti Pharma is a biopharmaceutical company that consists of three business units: Immunology and Allergy, Dermatology, and Animal Health. As an independent and family-owned company, Leti Pharma is dedicated to biopharmaceutical research and the development of products that contribute to healthcare. Their goal is to provide products that add value to healthcare, focusing on disease prevention, early diagnosis, and special body care.

Leti Pharma prioritizes health as a highly profitable investment rather than an expense to be minimized. They believe that improving health and quality of life reduces the incidence and social cost of illness. With headquarters in Barcelona and a plant and allergy research laboratory in Tres Cantos, Leti Pharma operates internationally with subsidiaries in Germany and Portugal.

They collaborate with exclusive distributors in Europe, Latin America, and Africa, fostering partnerships to enhance their penetration in foreign markets. Research and expertise are fundamental to Leti Pharma's strategy, with 10-20% of their revenue allocated to research and product development. Internationalization is a key element of their growth strategy, allowing them to expand their reach and offer their own products developed through research.

Leti Pharma's commitment to innovation and partnerships ensures they continue to make a positive impact on healthcare worldwide